Head-to-head comparison of plasma and PET imaging ATN markers in subjects with cognitive complaints.
Jiaying LuXiaoxi MaHuiwei ZhangZhenxu XiaoMing LiJie WuZizhao JuLi ChenLi ZhengJingjie GeXiaoniu LiangWeiqi BaoPing WuDing DingTzu-Chen YenYihui GuanChuan-Tao ZuoQianhua Zhaonull nullPublished in: Translational neurodegeneration (2023)
F-FDG PET imaging could serve as biomarkers for the severity of cognitive impairment. Our findings have implications for establishing a roadmap to identifying the most suitable ATN biomarkers for clinical use.